{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:58:04Z","timestamp":1772859484486,"version":"3.50.1"},"reference-count":21,"publisher":"ALUNA","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>The aim \u2013 to consider the etiopathogenesis, the main clinical manifestations, diagnostic criteria of NF1, and present a clinical case from their practice. The paper analyzes the research findings in recent publications, focused on the studied issue using the methods of continuous sampling, synthesis and generalization, bibliosemantic evaluation and content analysis. In order to attract the attention of family physicians, neurologists, dermatologists, ophthalmologists, surgeons and other specialists, we present our own clinical observation of NF1. \nThe patient was examined using the methods of neurological examination, as well as other laboratory and instrumental methods of research. Early diagnosis and medical examination of patients with NF1 is crucial for predicting and improving the quality of life of patients. NF1 is a complex disease where the cooperation of doctors of different specialties is important. A favorable prognosis for patients is associated with the possibility of early diagnosis of malignant transformation and timely treatment.<\/jats:p>","DOI":"10.36740\/wlek202205231","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:38:20Z","timestamp":1656344300000},"page":"1408-1414","source":"Crossref","is-referenced-by-count":1,"title":["NEUROFIBROMATOSIS TYPE I AND ITS DIAGNOSTIC CRITERIA: A CLINICAL OBSERVATION"],"prefix":"10.36740","volume":"75","author":[{"given":"T\u0435tiana I.","family":"Purdenko","sequence":"first","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mykhailo Yu.","family":"Delva","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liudmyla I.","family":"Ostrovskaya","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kateryna A.","family":"Tarianyk","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halyna Ya.","family":"Sylenko","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr O.","family":"Pushko","sequence":"additional","affiliation":[{"name":"POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serhii V.","family":"Purdenko","sequence":"additional","affiliation":[{"name":"MUNICIPAL ENTERPRISE, \u00ab3RD CITY CLINICAL HOSPITAL OF POLTAVA CITY COUNCIL\u00bb, POLTAVA, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref0","unstructured":"1. Sakhanova A.S.H., Kenzhebayeva K.A., Babiy D.V. et al. Neyrofibromatoz u detey [Neurofibromatosis in children]. Meditsina i ekologiya. 2017; 1:47-54 (in Russian)."},{"key":"ref1","unstructured":"2. Fomenko N.M., Synovers'ka O.B., Tsymbalista O.L. et al. Neyrofibromatoz I typu na Prykarpatti. Vypadok hihant\u00b7s'koyi neyrofibromy u dytyny [Neurofibromatosis type I in the Carpathians. A case of giant neurofibroma in a child]. Suchasna pediatriya. 2019; 4 (100): 75-78 (in Ukrainian)."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Karaconji T., Whist E., Jamieson R.V. et al. Neurofibromatosis Type 1: Review and Update on Emerging Therapies. Asia Pac J Ophthalmol (Phila). 2019;8(1):62-72.","DOI":"10.22608\/apo.2018182"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4. Neustroyeva L.M., Pavlova N.I., Solov\u2019yeva N.A. et al. Neyrofibromatoz \u00cd tipa: etiopatogenez, klinika, diagnostika, lecheniye [Type I neurofibromatosis: etiopathogenesis, clinical picture, diagnosis, treatment.]. Yakutskiy meditsinskiy zhurnal. 2018;1:69-73 (in Russian).","DOI":"10.25789\/YMJ.2018.61.21"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Sadykova D.I., Safina L.Z., Kadyrmetov R.A. Pozdnyaya diagnostika neyrofibromatoza 1-go tipa u 14-letnego yunoshi [Late diagnosis of type 1 neurofibromatosis in a 14-year-old boy]. Rossiyskiy vestnik perinatologii i pediatrii. 2017; 62:(4): 88-92 (in Russian).","DOI":"10.21508\/1027-4065-2017-62-4-88-92"},{"key":"ref5","unstructured":"6. Myslibors'ka Ya.V. Neyrofibromatoz I typu. Klinichni problemy v praktytsi ortopeda [Neurofibromatosis type I. Clinical problems in the orthopedist\u2019s practice]. Problemy osteolohiyi. 2014; 17(4): 64-70 (in Ukrainian)."},{"key":"ref6","unstructured":"7. Skvarskaya Ye.A. Neyrofibromatoz: etiologiya, patogenez, lecheniye [Neurofibromatosis: etiology, pathogenesis, treatment]. Mezhdunarodnyy zhurnal pediatrii, akusherstva i ginekologii. 2014;5(2): 56-63 (in Russian)."},{"key":"ref7","unstructured":"8. Ufimtseva M.A., Bochkarev Yu., Gal\u2019perin A.M. et al. Kozhnyye pryavleniya bolezni Reklingkhauzena [Skin manifestations of Recklinghausen\u2019s disease]. Sovremennyye problemy nauki i obrazovaniya. 2016;6 (in Russian)."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9. Dudnyk V.M., Furman V.H., Demyanyshyna V.V. Klinichni osoblyvosti neyrofibromatozu 1 typu u ditey: asotsiatsiya z prymityvnoyu neyroektodermal'noyu pukhlynoyu [Clinical features of neurofibromatosis type 1 in children: association with primitive neuroectodermal tumor.]. Perynatolohiya y pediatriya. 2017; 4: 106-114 (in Ukrainian).","DOI":"10.15574\/PP.2017.72.106"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Antoniolli L.P., Milman L.M., Bonamigo R.R. Dermoscopy of the iris: identification of Lisch nodules and contribution to the diagnosis of Neurofibromatosis type 1. An Bras Dermatol. 2021;96(4):487-489.","DOI":"10.1016\/j.abd.2020.09.007"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. De Bella K., Szudek J., Friedman J.M. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000; 105: 608-614.","DOI":"10.1542\/peds.105.3.608"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Hirbe A.C, Gutmann D.H. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014;13:834-843.","DOI":"10.1016\/s1474-4422(14)70063-8"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Sabbagh A., Pasmant E., Imbard A. et al. NF1 molecular characterization and neurofibromatosis type 1 genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34:1510-1518.","DOI":"10.1002\/humu.22392"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Gara S., Jones M., Litaiem N. et al. Dermoscopy is a useful tool for diagnosing lisch nodules on brown eyes. Int J Dermatol. 2020;59(7):880-881.","DOI":"10.1111\/ijd.14886"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Hern\u00e1ndez-Mart\u00edn A., Duat-Rodr\u00edguez A. An Update on Neurofibromatosis Type 1: Not Just Caf\u00e9-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer. Actas Dermosifiliogr. 2016;107(6):465-473.","DOI":"10.1016\/j.adengl.2016.05.019"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Kinori M., Hodgson N., Zeid J.L. Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol. 2018;63(4):518-533.","DOI":"10.1016\/j.survophthal.2017.10.007"},{"key":"ref16","unstructured":"17. Purdenko T.I., Ostrovskaya L.I., Lytvynenko N.V. et al. Do problemy synkopal'nykh staniv v nevrolohichniy praktytsi [To the problem of syncopal states in neurological practice]. Wiadomos\u0301ci lekarskie. 2018; 71(9): 1823-1828 (in Ukrainian)."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18. Purdenko T.Y. Sinkopal\u2019nyie neyrogennyie i kardiogennyie sostoyaniya [Syncope neurogenic and cardiogenic states]. Svit medytsyny ta biolohiyi. 2015;2(50):211-215 (in Russian).","DOI":"10.1111\/hea.12045_33"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19. Pobric G., Taylor J.R., Ramalingam H.M. et al. Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1. J Autism Dev Disord. 2021;1:21.","DOI":"10.1007\/s10803-021-05043-3"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Delva M.Yu., Delva I.I. Analysis of primary headaches management in Poltava regions. Wiadomos\u0301ci lekarskie. 2021;74(1):118-121.","DOI":"10.36740\/wlek202101123"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Warrington N.M., Gianino S.M., Jackson E. et al. Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. Cancer Res. 2010;70:5717-5727.","DOI":"10.1158\/0008-5472.can-09-3769"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:38:31Z","timestamp":1656344311000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2022\/05\/WLek202205231.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202205231","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}